149 Results

People

  1. Chi
    Chi
  2. Barakat
    Barakat
  3. Spriggs
    Spriggs
  4. Abu-Rustum
    Abu-Rustum
  5. Aghajanian
    Aghajanian
  6. Sabbatini
    Sabbatini
  7. Sonoda
    Sonoda
  8. Iasonos
    Iasonos
  9. Hensley
    Hensley
  10. Levine
    Levine

Groups

  1. Gynecology Disease Management Team (75)
  2. Surgery (70)
  3. Department of Medicine (56)
  4. Solid Tumor Oncology Division (55)
  5. GDMT, Surgery (46)
  6. Gynecologic Medicine Service (44)
  7. GDMT, Medicine (42)
  8. Epidemiology and Biostatistics (23)
  9. Biostatistics Service (22)
  10. Survivorship Research (17)
  1. "ca 125 antigen"
Formats
  1. Journal Article (145)
  2. Conference Paper (2)
  3. Guidelines (1)
  4. Review (1)
Groups
  1. Gynecology Disease Management Team (75)
  2. Surgery (70)
  3. Department of Medicine (56)
  4. Solid Tumor Oncology Division (55)
  5. GDMT, Surgery (46)
  6. Gynecologic Medicine Service (44)

More Groups

People
  1. Dennis Chi (31)
  2. Richard Barakat (24)
  3. David Spriggs (22)
  4. Paul Sabbatini (21)
  5. Nadeem Abu-Rustum (19)
  6. Carol Aghajanian (17)

More People

Years
  1. 2025 (3)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (2)
  5. 2021 (1)
  6. 2020 (4)

More Years

Publications
  1. Gynecologic Oncology (32)
  2. Journal of Clinical Oncology (13)
  3. International Journal of Gynecological Cancer (8)
  4. Cancer (6)
  5. Gynecologic Oncology Reports (5)
  6. Clinical Cancer Research (3)

More Publications

Publishers
  1. Elsevier Inc. (41)
  2. American Society of Clinical Oncology (13)
  3. Lippincott Williams & Wilkins (13)
  4. Springer (8)
  5. Wiley Blackwell (8)
  6. American Association for Cancer Research (7)

More Publishers

Results (149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Borderline tumors of the ovary
    Journal Article

    Barakat, R. R.
    Obstetrics and Gynecology Clinics of North America (1994)

    Fulltext@MSK | Save
  • Screening for cancer: Is it cost effective?
    Journal Article

    Schwartz, M. K.
    Clinical Chemistry (1993)

    Fulltext@MSK | Save
  • Relationship between saliva and serum CA 125 in women with and without epithelial ovarian cancer
    Journal Article

    Plante, M.; Wong, G. Y.; Nisselbaum, J. S.; Almadrones, L.; Hoskins, W. J.; Rubin, S. C.
    Obstetrics and Gynecology (1993)

    Fulltext@MSK | Save
  • Monoclonal antibodies in the management of ovarian cancer: A clinical perspective
    Conference Paper

    Rubin, S. C.
    Wiley Blackwell (1993)

    Fulltext@MSK | Save
  • Exploring the use of chronic low-dose oral etoposide in ovarian cancer: Is there a role for this "new drug" in the management of platinum-refractory disease?
    Journal Article

    Markman, M.; Hakes, T.; Reichman, B.; Barakat, R.; Curtin, J.; Jones, W.; Lewis, J. L. Jr; Rubin, S.; Almadrones, L.; Hoskins, W.
    Seminars in Oncology (1992)

    Fulltext@MSK | Save
  • Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapy
    Journal Article

    Markman, M.; Reichman, B.; Hakes, T.; Curtin, J.; Barakat, R.; Rubin, S.; Jones, W.; Lewis, J. L. Jr; Almadrones, L.; Hoskins, W.
    Journal of Cancer Research and Clinical Oncology (1992)

    Fulltext@MSK | Save
  • Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer
    Journal Article

    Rubin, S. C.; Hoskins, W. J.; Hakes, T. B.; Markman, M.; Reichman, B. S.; Chapman, D.; Lewis, J. L. Jr
    American Journal of Obstetrics and Gynecology (1989)

    Fulltext@MSK | Save
  • Ovarian cancer, inflammation, and CA-125
    Journal Article

    Markman, M.; Hoskins, W. B.
    Annals of Internal Medicine (1989)

    Fulltext@MSK | Save
  • Tumor markers: Can they be used for screening?
    Journal Article

    Schwartz, M. K.
    Journal of Tumor Marker Oncology (1987)

    Fulltext@MSK | Save